CMND
Price
$0.89
Change
-$0.01 (-1.11%)
Updated
Jun 27 closing price
Capitalization
4.78M
MBXBF
Price
$0.22
Change
-$0.00 (-0.00%)
Updated
Jun 27 closing price
Capitalization
30.85M
Interact to see
Advertisement

CMND vs MBXBF

Header iconCMND vs MBXBF Comparison
Open Charts CMND vs MBXBFBanner chart's image
Clearmind Medicine
Price$0.89
Change-$0.01 (-1.11%)
Volume$56.83K
Capitalization4.78M
Microbix Biosystems
Price$0.22
Change-$0.00 (-0.00%)
Volume$4.72K
Capitalization30.85M
CMND vs MBXBF Comparison Chart in %
Loading...
CMND
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
MBXBF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CMND vs. MBXBF commentary
Jun 30, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CMND is a Buy and MBXBF is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 30, 2025
Stock price -- (CMND: $0.89 vs. MBXBF: $0.22)
Brand notoriety: CMND and MBXBF are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CMND: 63% vs. MBXBF: 15%
Market capitalization -- CMND: $4.78M vs. MBXBF: $30.85M
CMND [@Biotechnology] is valued at $4.78M. MBXBF’s [@Biotechnology] market capitalization is $30.85M. The market cap for tickers in the [@Biotechnology] industry ranges from $304.6B to $0. The average market capitalization across the [@Biotechnology] industry is $2.32B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CMND’s FA Score shows that 1 FA rating(s) are green whileMBXBF’s FA Score has 1 green FA rating(s).

  • CMND’s FA Score: 1 green, 4 red.
  • MBXBF’s FA Score: 1 green, 4 red.
According to our system of comparison, CMND is a better buy in the long-term than MBXBF.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CMND’s TA Score shows that 5 TA indicator(s) are bullish while MBXBF’s TA Score has 5 bullish TA indicator(s).

  • CMND’s TA Score: 5 bullish, 3 bearish.
  • MBXBF’s TA Score: 5 bullish, 2 bearish.
According to our system of comparison, MBXBF is a better buy in the short-term than CMND.

Price Growth

CMND (@Biotechnology) experienced а +0.28% price change this week, while MBXBF (@Biotechnology) price change was -2.13% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.13%. For the same industry, the average monthly price growth was +31.22%, and the average quarterly price growth was +12.91%.

Industries' Descriptions

@Biotechnology (+4.13% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
MBXBF($30.9M) has a higher market cap than CMND($4.78M). MBXBF has higher P/E ratio than CMND: MBXBF (27.25) vs CMND (0.17). MBXBF YTD gains are higher at: -24.360 vs. CMND (-35.580). MBXBF has higher annual earnings (EBITDA): 4.35M vs. CMND (-4.65M). MBXBF has more cash in the bank: 14.5M vs. CMND (5.92M). CMND has less debt than MBXBF: CMND (46K) vs MBXBF (5.35M). MBXBF has higher revenues than CMND: MBXBF (22.7M) vs CMND (0).
CMNDMBXBFCMND / MBXBF
Capitalization4.78M30.9M15%
EBITDA-4.65M4.35M-107%
Gain YTD-35.580-24.360146%
P/E Ratio0.1727.251%
Revenue022.7M-
Total Cash5.92M14.5M41%
Total Debt46K5.35M1%
FUNDAMENTALS RATINGS
MBXBF: Fundamental Ratings
MBXBF
OUTLOOK RATING
1..100
36
VALUATION
overvalued / fair valued / undervalued
1..100
78
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
82
PRICE GROWTH RATING
1..100
85
P/E GROWTH RATING
1..100
7
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
CMNDMBXBF
RSI
ODDS (%)
Bullish Trend 4 days ago
77%
Bullish Trend 4 days ago
62%
Stochastic
ODDS (%)
Bearish Trend 4 days ago
89%
Bullish Trend 4 days ago
63%
Momentum
ODDS (%)
Bullish Trend 4 days ago
76%
Bearish Trend 5 days ago
71%
MACD
ODDS (%)
Bullish Trend 4 days ago
86%
Bullish Trend 4 days ago
63%
TrendWeek
ODDS (%)
Bullish Trend 4 days ago
73%
Bearish Trend 4 days ago
74%
TrendMonth
ODDS (%)
Bearish Trend 4 days ago
90%
Bearish Trend 4 days ago
77%
Advances
ODDS (%)
Bullish Trend 11 days ago
77%
Bullish Trend 5 days ago
65%
Declines
ODDS (%)
Bearish Trend 19 days ago
88%
N/A
BollingerBands
ODDS (%)
Bullish Trend 4 days ago
84%
Bullish Trend 4 days ago
66%
Aroon
ODDS (%)
Bearish Trend 4 days ago
90%
Bearish Trend 4 days ago
77%
View a ticker or compare two or three
Interact to see
Advertisement
CMND
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
MBXBF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
SAUHY13.050.12
+0.93%
Straumann Holding AG
MBKL21.100.05
+0.24%
MBT Bancshares, Inc.
FPRUY36.31N/A
N/A
Fraport AG
FYMNF0.07N/A
N/A
Finlay Minerals Ltd
LSDAF154.54N/A
N/A
Lassonde Industries Inc.

CMND and

Correlation & Price change

A.I.dvisor indicates that over the last year, CMND has been loosely correlated with SLRN. These tickers have moved in lockstep 38% of the time. This A.I.-generated data suggests there is some statistical probability that if CMND jumps, then SLRN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CMND
1D Price
Change %
CMND100%
+0.84%
SLRN - CMND
38%
Loosely correlated
N/A
HURA - CMND
32%
Poorly correlated
-0.45%
CDT - CMND
32%
Poorly correlated
N/A
NEUP - CMND
32%
Poorly correlated
+2.94%
BIVI - CMND
30%
Poorly correlated
-1.94%
More

MBXBF and

Correlation & Price change

A.I.dvisor tells us that MBXBF and CMND have been poorly correlated (+25% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that MBXBF and CMND's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MBXBF
1D Price
Change %
MBXBF100%
-0.64%
CMND - MBXBF
25%
Poorly correlated
+0.84%
BVNRY - MBXBF
20%
Poorly correlated
+1.20%
MMIRF - MBXBF
15%
Poorly correlated
N/A
IVEVF - MBXBF
8%
Poorly correlated
N/A
IVBXF - MBXBF
7%
Poorly correlated
-1.18%
More